Navigation Links
ProCertus BioPharm secures $2.3M in financing

Madison, Wis. - A Madison company that is developing drugs to protect cancer patients from common side effects of chemotherapy and radiotherapy has closed on a Series A Preferred Stock financing led by Venture Investors of Madison.

ProCertus BioPharm, an oncology-based pharmaceutical company, will ......

Full article >>> ious stages, when potential corporate partners were interested in its technology and any human data associated with it, Fahl said the new executives will be important in managing the infusion of venture capital and in identifying large pharmaceutical partners to help develop the technology and bring it to market.

Venture Investors traditionally has looked for investments in companies with......

Full article >>> five clinical studies to establish safety and efficacy for each.

Of the three drug candidates, Fahl said OralX is the only one that would face a competitive product on the market, and that particular therapy has limited efficacy.

Lab results

The inventions associated the company's intellectual property are derived from research done in Fahls laboratory. In additi......

Full article >>>
'"/> By WTN News 05/11/07

Related biology technology :

1. Glossary for The BioPharm Guide to Fermentation and Cell Culture
2. TrafficCast secures $2M from Phenomenelle Angels, NEW Capital Fund
3. Perscitus Biosciences secures $250K Commerce loan
4. Mirus Bio secures $900K grant to develop research tool
5. BioSystem Development secures angel funding
6. TrafficCast secures $1 million line of credit
7. Medical College secures $9.7M research grant
8. Wausau start up secures $560K for GPS maps
9. Platypus Technologies secures $450K SBIR grant
10. Congresswoman Baldwin secures Federal Funds for UW-Rock County
11. 2006: A great biotech financing year, unless you were going public!
Post Your Comments:

(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... ... ... The United States Golf Association (USGA) today announced Dr. Bruce Clarke, of ... since 1961, the USGA Green Section Award recognizes an individual’s distinguished service to the ... of Iselin, N.J., is an extension specialist of turfgrass pathology in the department of ...
(Date:11/24/2015)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. ... will provide a corporate overview. th Annual Oppenheimer ... p.m. ET/10:00 a.m. PT . Jim Mazzola , vice ... overview. --> th Annual Oppenheimer Healthcare Conference in ...
Breaking Biology Technology:
(Date:11/20/2015)... , November 20, 2015 ... company focused on the growing mobile commerce market and ... Gino Pereira , was recently interviewed on ... will air on this weekend on Bloomberg Europe ... America . --> NXTD ) ("NXT-ID" or ...
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... sale of broadly enabling, pressure cycling technology ("PCT")-based sample ... announced it has received gross proceeds of $745,000 from ... (the "Offering"), increasing the total amount raised to date ... closings are expected in the near future. ...
Breaking Biology News(10 mins):